uu.seUppsala universitets publikasjoner
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastoma
Vise andre og tillknytning
2014 (engelsk)Inngår i: Acta neuropathologica communications, ISSN 2051-5960, Vol. 2, artikkel-id 174Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

TP53 mutations confer subgroup specific poor survival for children with medulloblastoma. We hypothesized that WNT activation which is associated with improved survival for such children abrogates TP53 related radioresistance and can be used to sensitize TP53 mutant tumors for radiation. We examined the subgroup-specific role of TP53 mutations in a cohort of 314 patients treated with radiation. TP53 wild-type or mutant human medulloblastoma cell-lines and normal neural stem cells were used to test radioresistance of TP53 mutations and the radiosensitizing effect of WNT activation on tumors and the developing brain. Children with WNT/TP53 mutant medulloblastoma had higher 5-year survival than those with SHH/TP53 mutant tumours (100% and 36.6%±8.7%, respectively (p<0.001)). Introduction of TP53 mutation into medulloblastoma cells induced radioresistance (survival fractions at 2Gy (SF2) of 89%±2% vs. 57.4%±1.8% (p<0.01)). In contrast, beta-catenin mutation sensitized TP53 mutant cells to radiation (p<0.05). Lithium, an activator of the WNT pathway, sensitized TP53 mutant medulloblastoma to radiation (SF2 of 43.5%±1.5% in lithium treated cells vs. 56.6±3% (p<0.01)) accompanied by increased number of gammaH2AX foci. Normal neural stem cells were protected from lithium induced radiation damage (SF2 of 33%±8% for lithium treated cells vs. 27%±3% for untreated controls (p=0.05). Poor survival of patients with TP53 mutant medulloblastoma may be related to radiation resistance. Since constitutive activation of the WNT pathway by lithium sensitizes TP53 mutant medulloblastoma cells and protect normal neural stem cells from radiation, this oral drug may represent an attractive novel therapy for high-risk medulloblastomas.

sted, utgiver, år, opplag, sider
2014. Vol. 2, artikkel-id 174
HSV kategori
Identifikatorer
URN: urn:nbn:se:uu:diva-262220DOI: 10.1186/s40478-014-0174-yPubMedID: 25539912OAI: oai:DiVA.org:uu-262220DiVA, id: diva2:852792
Tilgjengelig fra: 2015-09-10 Laget: 2015-09-10 Sist oppdatert: 2015-09-10bibliografisk kontrollert

Open Access i DiVA

fulltext(2438 kB)70 nedlastinger
Filinformasjon
Fil FULLTEXT01.pdfFilstørrelse 2438 kBChecksum SHA-512
1a179c9fef8aab1c7345f93a1cf19eabd306ee4571551f2285e2125c2330a3a5e6576126704ecb5250178d9de4f3756641cd55f34e214a48942b42b8e9e3d20a
Type fulltextMimetype application/pdf

Andre lenker

Forlagets fulltekstPubMed

Personposter BETA

Baskin, Berivan

Søk i DiVA

Av forfatter/redaktør
Baskin, Berivan
Av organisasjonen

Søk utenfor DiVA

GoogleGoogle Scholar
Totalt: 70 nedlastinger
Antall nedlastinger er summen av alle nedlastinger av alle fulltekster. Det kan for eksempel være tidligere versjoner som er ikke lenger tilgjengelige

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 453 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf